Shanghai Hile Bio-Technology Co., Ltd.
Status: Publicly traded
Direct answer
Shanghai Hile Bio-Technology Co., Ltd. is publicly traded on SHH under the ticker 603718.SS.
Shanghai Hile Bio-Technology Co., Ltd. develops, manufactures, and sells in vitro diagnostic reagents and oral tissue repair and regeneration materials in China. It operates through two segments: In Vitro Diagnostic Reagents and Oral Tissue Repair and Regeneration Materials. The In Vitro Diagnostic Reagents segment offers biochemical diagnostic reagents, immuno-latex reagents, immune turbidimetry reagents, latex...
Can you invest in Shanghai Hile Bio-Technology Co., Ltd.?
Yes. Shanghai Hile Bio-Technology Co., Ltd. trades publicly on SHH as 603718.SS.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Shanghai Hile Bio-Technology Co., Ltd.
Detailed equity research is provided by MarketSnap.